Hepatitis C virus genotype 5 variability in treatment naïve patients in South Africa
Introduction. Hepatitis C virus (HCV) genotype 5 was originally identified in South Africa, where it represents 35-60% of all HCV infections. There are limited data on resistance associated variants (RAVs) in South Africa. Thus, we investigated variability within the NS3/NS4A, NS5A, and NS5B gene...
Main Authors: | Tshegofatso K. Maunye, Maemu P. Gededzha, Jason T. Blackard, Johnny N. Rakgole, Selokela G. Selabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-05-01
|
Series: | Intervirology |
Online Access: | https://beta.karger.com/Article/FullText/528178 |
Similar Items
-
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
by: Azwidowi Lukhwareni, et al.
Published: (2020-06-01) -
The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa
by: Kebareng Rakau, et al.
Published: (2022-12-01) -
Hepatitis B virus infection in patients presenting for immunosuppressive cancer therapy with and without underlying HIV infection
by: Malowane H. Ngoato, et al.
Published: (2023-09-01) -
Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique.
by: Ann Mathew, et al.
Published: (2023-01-01) -
Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique
by: Ann Mathew, et al.
Published: (2023-01-01)